摘要
临床试验数据共享可增加临床试验的透明度,提高临床试验的真实性。现有的临床试验数据透明化要求并不完善,要达到临床试验数据共享常态化,目前尚面临着较多问题。本文分析了临床试验数据共享工作存在的各种问题,并在数据所有权、技术、操作和法律层面等方面提出了解决思考,呼吁临床试验数据共享,以促进临床试验透明化工作,最大限度地降低临床试验风险,使数据共享发挥最大效益。
Sharing clinical trial data can increase the transparency of clinical trials and improve the its authenticity. The current requirements of clinical research data transparency is not fully adequate, and it is still difficult to create an environment in which the sharing of the clinical trial data becomes the norm. The article analyzed various concerns on data sharing and proposed solutions in data ownership, technology, implementation, and legal issues systematically, calling for clinical trial data sharing in order to promote transparency of clinical trials, and looking forward to minimize the risks and maximize the benefits of data sharing.
作者
林伟青
田然
赵晨
商洪才
吴泰相
李幼平
卞兆祥
LAM Wai Ching;TIAN Ran;ZHAO Chen;SHANG Hongcai;WU Taixiang;LI Youping;BIAN Zhaoxiang(School of Chinese Medicine,Hong Kong Baptist University,Hongkong,999077,P.R.China;Dongzhimen Hospital,Beifing University of Chinese Medicine,Belting,100700,P.R.China;Chinese Evidence-based Medicine Center,West China Hospital,Sichuan University,Chengdu,610041,P.R.China)
出处
《中国循证医学杂志》
CSCD
北大核心
2018年第9期893-895,共3页
Chinese Journal of Evidence-based Medicine
关键词
临床试验
数据共享
透明化
临床试验真实性
Clinical trial
Data sharing
Transparency
Authenticity of clinical trial